: The c-CbI protooncogene was isolated as a cellular homologue of v-Cbl oncogene. The 120-kDa product of c-CbI, CbI, is composed of an amino-terminal variant SH2 domain, a RING finger, and a carboxy terminal proline-rich domain with potential tyrosine phosphorylation sites. CbI is rapidly tyrosine phosphorylated upon engagement of a wide range of cell surface receptors including T cell antigen receptor (TCR), suggesting its role in signal transduction. Numerous biochemical studies have showed that Cbl acts as an adaptor protein by interacting with protein tyrosine kinases and other critical signal molecules to form Cbl complexes. Genetic studies showed that Cbl is a negative regulator in TCR-mediated signaling and is involved in fine-tuning of the signals required for thymocyte development. One of the most recent significant developments is the discovery that Cbl functions as an E3 ubiquitin (Ub) ligase, whose RING finger recruit Ub conjugation enzyme and whose variant SH2 domain binds to activated receptor tyrosine kinases, and that Cbl then facilitates Ub conjugation to the protein tyrosine kinases it associates with. However, the molecular mechanisms that link Cbl E3 Ub ligase activity and its negative regulation of T cell development and activation remain unclear. The working hypotheses which serve as a basis for this application of competitive renewal are that: First, Cbl, both as an adaptor protein and an E3 ligase, targets protein substrates for Ub conjugation through the interaction of Cbl protein binding domains and through the RING finger-dependent recruitment of Ubc E2s; Second, Cbl negatively regulates intracellular signal transduction in thymocytes and peripheral T cells via ubiquitination of its binding proteins; and Third, Cbl, as an E3 Ub ligase, is involved in the thymocyte development and the generation of hyporesponsive peripheral T cells. Deficiency of Cbl may change the threshold of T cell activation and induce breakdown of self-tolerance and the onset of autoimmune responses. The long-term goal is to understand how Cbl is involved in T cell tolerance induction under physiological conditions and the development of abnormal immune responses under pathological conditions, which may lead to new therapeutic approaches for the treatment of immunological diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK056558-08
Application #
7033838
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Spain, Lisa M
Project Start
1999-05-01
Project End
2008-03-31
Budget Start
2006-04-01
Budget End
2008-03-31
Support Year
8
Fiscal Year
2006
Total Cost
$251,369
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Liu, Yun-Cai (2004) Ubiquitin ligases and the immune response. Annu Rev Immunol 22:81-127
Shao, Yuan; Yang, Chun; Elly, Chris et al. (2004) Differential regulation of the B cell receptor-mediated signaling by the E3 ubiquitin ligase Cbl. J Biol Chem 279:43646-53
Shao, Yuan; Elly, Chris; Liu, Yun-Cai (2003) Negative regulation of Rap1 activation by the Cbl E3 ubiquitin ligase. EMBO Rep 4:425-31
Zhang, Wenying; Shao, Yuan; Fang, Deyu et al. (2003) Negative regulation of T cell antigen receptor-mediated Crk-L-C3G signaling and cell adhesion by Cbl-b. J Biol Chem 278:23978-83
Fang, Deyu; Elly, Chris; Gao, Baixue et al. (2002) Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat Immunol 3:281-7
Fang, D; Wang, H Y; Fang, N et al. (2001) Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J Biol Chem 276:4872-8
Fang, D; Liu, Y C (2001) Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol 2:870-5
Qiu, L; Joazeiro, C; Fang, N et al. (2000) Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J Biol Chem 275:35734-7
Joazeiro, C A; Wing, S S; Huang, H et al. (1999) The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286:309-12